• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄对依诺沙星药代动力学的影响。

The effect of age on the pharmacokinetics of enoxacin.

作者信息

Dobbs B R, Gazeley L R, Campbell A J, Edwards I R

机构信息

Medical Research Council Toxicology Research Unit, University of Otago Medical School, Dunedin, New Zealand.

出版信息

Eur J Clin Pharmacol. 1987;33(1):101-4. doi: 10.1007/BF00610390.

DOI:10.1007/BF00610390
PMID:3480221
Abstract

We have studied the pharmacokinetics of enoxacin in two groups of subjects, 10 young (18-45 years) and 10 elderly adults (greater than 65 years) after a single oral dose of enoxacin (600 mg). Enoxacin was absorbed rapidly, peak plasma concentrations being reached within two hours in both groups. However, the peak plasma concentration of enoxacin was significantly higher in the elderly than in the young adults. The area under the concentration-time curve extrapolated to infinity was also significantly greater in the elderly compared with the young subjects, and the apparent renal clearance was significantly less in the elderly than in the young adults. Consequently, the urinary elimination of unchanged enoxacin was significantly reduced in the elderly. The apparent volume of distribution in the elderly was significantly less than in the young adults. The elimination half-time of enoxacin was similar in the two groups.

摘要

我们研究了两组受试者单次口服600毫克依诺沙星后的药代动力学情况,一组为10名年轻人(18至45岁),另一组为10名老年人(大于65岁)。依诺沙星吸收迅速,两组均在两小时内达到血浆峰浓度。然而,老年人的依诺沙星血浆峰浓度显著高于年轻人。与年轻受试者相比,老年人浓度-时间曲线外推至无穷大时的曲线下面积也显著更大,且老年人的表观肾清除率显著低于年轻人。因此,老年人中未改变的依诺沙星经尿液排泄量显著减少。老年人的表观分布容积显著小于年轻人。两组中依诺沙星的消除半衰期相似。

相似文献

1
The effect of age on the pharmacokinetics of enoxacin.年龄对依诺沙星药代动力学的影响。
Eur J Clin Pharmacol. 1987;33(1):101-4. doi: 10.1007/BF00610390.
2
The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin.
J Antimicrob Chemother. 1988 Feb;21 Suppl B:87-95. doi: 10.1093/jac/21.suppl_b.87.
3
Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
J Antimicrob Chemother. 1988 Feb;21 Suppl B:49-56. doi: 10.1093/jac/21.suppl_b.49.
4
Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
J Antimicrob Chemother. 1988 Feb;21 Suppl B:61-6. doi: 10.1093/jac/21.suppl_b.61.
5
Elimination of enoxacin in renal disease.依诺沙星在肾脏疾病中的消除情况。
Clin Pharmacol Ther. 1987 Apr;41(4):434-8. doi: 10.1038/clpt.1987.53.
6
Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.依诺沙星的药代动力学及其在支气管分泌物和肺组织中的渗透情况。
J Antimicrob Chemother. 1988 Feb;21 Suppl B:67-77. doi: 10.1093/jac/21.suppl_b.67.
7
Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.喹诺酮类药物在志愿者体内的药代动力学:拟议的给药方案。
Rev Infect Dis. 1988 Jan-Feb;10 Suppl 1:S83-9.
8
Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.肾衰竭、类风湿关节炎及老年对二氟尼柳药代动力学的影响。
Eur J Clin Pharmacol. 1989;36(2):165-74. doi: 10.1007/BF00609190.
9
Enoxacin distribution in human tissues after multiple oral administration.
J Antimicrob Chemother. 1988 Feb;21 Suppl B:57-60. doi: 10.1093/jac/21.suppl_b.57.
10
Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections.老年复杂性尿路感染患者静脉注射至口服依诺沙星的药代动力学和生物利用度
Antimicrob Agents Chemother. 1990 Oct;34(10):1966-72. doi: 10.1128/AAC.34.10.1966.

引用本文的文献

1
Quantifying Reoxygenation in Pancreatic Cancer During Stereotactic Body Radiotherapy.定量立体定向体部放疗期间胰腺癌的再氧合。
Sci Rep. 2020 Jan 31;10(1):1638. doi: 10.1038/s41598-019-57364-0.
2
Quinolones in the aged.老年人中的喹诺酮类药物
Drugs. 1999;58 Suppl 2:49-51. doi: 10.2165/00003495-199958002-00009.
3
Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.依诺沙星:对其治疗泌尿生殖道感染临床疗效的重新评估。

本文引用的文献

1
Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.十种抗菌剂对细菌性肠道病原体的体外活性比较
Antimicrob Agents Chemother. 1983 Oct;24(4):509-13. doi: 10.1128/AAC.24.4.509.
2
Nomogram for estimating creatinine clearance.估算肌酐清除率的列线图。
Clin Pharmacokinet. 1983 Jul-Aug;8(4):365-9. doi: 10.2165/00003088-198308040-00007.
3
In vitro activities of enoxacin and 17 other antimicrobial agents against multiply resistant, gram-negative bacteria.依诺沙星及其他17种抗菌剂对多重耐药革兰氏阴性菌的体外活性
Drugs. 1996 Jan;51(1):137-60. doi: 10.2165/00003495-199651010-00009.
4
Quinolones in the elderly.老年人中的喹诺酮类药物
Drugs. 1995;49 Suppl 2:112-4. doi: 10.2165/00003495-199500492-00017.
5
Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.依诺沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1988 Jul;36(1):32-66. doi: 10.2165/00003495-198836010-00004.
6
Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection and dosage.抗菌药物在老年人中的临床药代动力学。对药物选择和剂量的影响。
Clin Pharmacokinet. 1989 Dec;17(6):385-95. doi: 10.2165/00003088-198917060-00003.
7
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
8
Enoxacin absorption and elimination characteristics.
Clin Pharmacokinet. 1989;16 Suppl 1:52-8. doi: 10.2165/00003088-198900161-00009.
9
Saturable pharmacokinetics in the renal excretion of drugs.药物经肾排泄的饱和药代动力学
Clin Pharmacokinet. 1989 Jan;16(1):38-54. doi: 10.2165/00003088-198916010-00003.
10
Preliminary study of the pharmacokinetics of oral amifloxacin in elderly subjects.老年受试者口服阿米氟沙星的药代动力学初步研究。
Antimicrob Agents Chemother. 1990 May;34(5):751-4. doi: 10.1128/AAC.34.5.751.
Antimicrob Agents Chemother. 1984 Jul;26(1):97-100. doi: 10.1128/AAC.26.1.97.
4
In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.新喹啉衍生物依诺沙星(CL-919)的体外活性与其他抗菌剂的比较。
J Antimicrob Chemother. 1984 Mar;13(3):237-44. doi: 10.1093/jac/13.3.237.
5
Pharmacokinetics in the elderly.老年人的药代动力学。
Int J Clin Pharmacol Res. 1984;4(6):425-9.
6
Comparative in vitro activities of enoxacin (CI-919, AT-2266) and eleven antipseudomonal agents against aminoglycoside-susceptible and -resistant Pseudomonas aeruginosa strains.依诺沙星(CI-919,AT-2266)与十一种抗铜绿假单胞菌药物对氨基糖苷类敏感和耐药的铜绿假单胞菌菌株的体外活性比较
Antimicrob Agents Chemother. 1984 Sep;26(3):417-8. doi: 10.1128/AAC.26.3.417.
7
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.体外筛选耐药菌群体后,西诺沙星、环丙沙星、DJ - 6783、依诺沙星、萘啶酸、诺氟沙星和恶喹酸之间的交叉耐药性。
Antimicrob Agents Chemother. 1984 Jun;25(6):775-7. doi: 10.1128/AAC.25.6.775.
8
Drug therapy in the elderly.
Aust N Z J Med. 1984 Apr;14(2):179-90. doi: 10.1111/j.1445-5994.1984.tb04290.x.
9
Aging and drug disposition: an update.衰老与药物处置:最新进展
Pharmacol Rev. 1985 Jun;37(2):133-48.
10
Enoxacin treatment of urinary tract infections.
J Antimicrob Chemother. 1985 Jun;15(6):759-63. doi: 10.1093/jac/15.6.759.